USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.64% | -5.33% | 0.27% | 5.89% | 6.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.64% | -5.33% | 0.27% | 5.89% | 6.72% |
| Cost of Revenue | -0.20% | -3.68% | 13.33% | 28.16% | 24.35% |
| Gross Profit | -4.66% | -5.78% | -3.20% | 0.99% | 2.42% |
| SG&A Expenses | -3.06% | -1.87% | -2.49% | 0.59% | 12.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.41% | -2.28% | 1.06% | 5.98% | 15.07% |
| Operating Income | -218.30% | -45.32% | -11.47% | 4.84% | -92.15% |
| Income Before Tax | -144.82% | -200.44% | -7.61% | -59.95% | -90.36% |
| Income Tax Expenses | -28.03% | 8.10% | 14.19% | -2.91% | 5.69% |
| Earnings from Continuing Operations | -3.42% | -367.63% | -25.09% | -135.57% | -162.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 852.86% | 932.57% | 396.43% | -500.00% | -- |
| Net Income | 14.81% | -321.46% | -20.07% | -139.85% | -161.49% |
| EBIT | -218.30% | -45.32% | -11.47% | 4.84% | -92.15% |
| EBITDA | -27.08% | -31.26% | -7.74% | 26.20% | -52.31% |
| EPS Basic | 15.74% | -321.80% | -17.24% | -141.61% | -164.12% |
| Normalized Basic EPS | -34.69% | 18.38% | 0.09% | -2.94% | -88.70% |
| EPS Diluted | 16.56% | -323.08% | -16.63% | -142.41% | -164.75% |
| Normalized Diluted EPS | -34.69% | 18.52% | 0.22% | -2.94% | -88.69% |
| Average Basic Shares Outstanding | 1.12% | -0.15% | -3.42% | -4.20% | -4.11% |
| Average Diluted Shares Outstanding | 1.12% | -0.27% | -3.53% | -4.20% | -4.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |